P38 One Size Does Not Fit All: Calculating the Cost-Effectiveness of Multiple Indications of Pembrolizumab in the Netherlands

Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.050
https://www.valueinhealthjournal.com/article/S1098-3015(22)02252-5/fulltext
Title : P38 One Size Does Not Fit All: Calculating the Cost-Effectiveness of Multiple Indications of Pembrolizumab in the Netherlands
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02252-5&doi=10.1016/j.jval.2022.09.050
First page :
Section Title :
Open access? : No
Section Order : 12244
Categories :
Tags :
Regions :
ViH Article Tags :